Acute intestinal inflammation transiently decreases frequency of colonic LP CD5⁺ B cells. by Yoshiyuki Mishima (842248)

V5-SgG2 transfection in the epidermis modifies the termination site of peptidergic FNE. by Jorge Rubén Cabrera (685511)

Determinants of decrease in COVID-19 immunity among vaccinated patients over a 6-month period using univariate analysis and multivariable logistic regression models. by Dalal Nour (18530615)

Dynamin inhibitors decrease the viability of acute leukemia cells. by Christopher von Beek (11401835)

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. by Udaysankar Chockanathan (18510288)

“…<p>(A) Spiking activity of representative neurons (black points) overlaid with animal trajectories on the virtual track (gray lines). …”

Dex treatemnt decreases body and muscle weight in mice. by Yanjun Dong (389082)

Absence of LFA-1 results in decreased numbers of NKT cells within the regenerating liver. by Ann-Kathrin Jörger (3559358)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Decreased number of cilia in partially formed KV lumen. by Jeong-gyun Kim (4330168)

2-NBDG₆₀ is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)

“…There are no significant differences between the 6 and 12-hour fasting groups. <b>C</b>. Blood glucose measurements were performed using a Freestyle Lite monitor by drawing 3 μl of blood from the tail of a separate cohort of mice (n = 5). …”

Rh-endostatin decreases microvascular density (MVD) and promotes vessel normalization of A549 lung carcinoma. by Shujing Shi (422263)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Transferrin secretion in medium of Müller glial cells from 8 to 12-day-old wild-type and transgenic mice decreases with the subcultures by Emilie Picard (79189)

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.</p> <p>Methods</p><p>Hepatic CYP3A activity and miRNA microarray expression profiles were measured in cirrhotic (n=28) and normal (n=12) liver tissue. …”

SP1049C treatment decreases tumor aggressiveness. by Daria Y. Alakhova (447558)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

Binding mode of clavulanic acid with active site residues of SHV wt at different time intervals (a) binding of ca at 0 ns (b) binding of ca at 2 ns (c) binding of ca at 5 ns (d) bi... by Mohd Hassan Baig (441304)

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)